Publications by authors named "Maria Dorn-Rasmussen"

Claim this Profile
I
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Maria Dorn-Rasmussen

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence and Prevalence of Paediatric- and Adult-Onset Inflammatory Bowel Disease in Denmark During a 37-Year Period: A Nationwide Cohort Study (1980-2017).
Maria Dorn-Rasmussen, Bobby Lo, Mirabella Zhao, Gilaad G Kaplan, Mikkel Malham

J Crohns Colitis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
Sine Buhl, Casper Steenholdt, Jørn Brynskov, Katrine Risager Christensen, Maria Dorn-Rasmussen

NEJM Evid· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.
Mohamed Attauabi, Gorm Roager Madsen, Flemming Bendtsen, Anne Vibeke Wewer, Rune Wilkens, Maria Dorn-Rasmussen

BMJ Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Maria Dorn-Rasmussen, Sine Buhl, Jørn Brynskov, Jakob T Bay, Nils Bolstad

Ther Drug Monit· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease.
Ana-Marija Grišić, Maria Dorn-Rasmussen, Bella Ungar, Jørn Brynskov, Johan F K F Ilvemark

United European Gastroenterol J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Sine Buhl, Maria Dorn-Rasmussen, Jørn Brynskov, Mark A Ainsworth, Klaus Bendtzen

Scand J Gastroenterol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis